BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Other News

Autifony, GlaxoSmithKline other news

GlaxoSmithKline spun out Autifony with an undisclosed number of preclinical assets targeting voltage-gated ion channels to treat noise-induced hearing loss and tinnitus. The company plans...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >